# Amgen Inc. (AMGN) FY2026 Q1 P&L / Income Statement

- Company: Amgen Inc. (AMGN)
- Period: 2026-01-01 to 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-01, accession number 0000318154-26-000057
- Page: https://plicit.ai/financials/amgn/fy2026-q1-income-statement
- Chart image: https://plicit.ai/charts/amgn-fy2026-q1-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2026-01-01 through 2026-03-31. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 8,618,000,000 US dollars
- **Cost of sales**: 2,744,000,000 US dollars
- **Gross profit (calculated)**: 5,874,000,000 US dollars
- **Operating expenses (calculated)**: 3,208,000,000 US dollars
- **Operating income**: 2,666,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 582,000,000 US dollars
- **Income before income taxes**: 2,084,000,000 US dollars
- **Provision for income taxes**: 265,000,000 US dollars
- **Net income**: 1,819,000,000 US dollars
- **Other revenues**: 400,000,000 US dollars
- **Aranesp - UNITED STATES**: 77,000,000 US dollars
- **Aranesp - Non-US**: 234,000,000 US dollars
- **BLINCYTO - UNITED STATES**: 221,000,000 US dollars
- **BLINCYTO - Non-US**: 194,000,000 US dollars
- **EVENITY - UNITED STATES**: 431,000,000 US dollars
- **EVENITY - Non-US**: 131,000,000 US dollars
- **ENBREL - UNITED STATES**: 314,000,000 US dollars
- **ENBREL - Non-US**: 6,000,000 US dollars
- **IMDELLTRA/IMDYLLTRA - UNITED STATES**: 188,000,000 US dollars
- **IMDELLTRA/IMDYLLTRA - Non-US**: 70,000,000 US dollars
- **KRYSTEXXA - UNITED STATES**: 255,000,000 US dollars
- **KRYSTEXXA - Non-US**: 0 US dollars
- **Kyprolis - UNITED STATES**: 218,000,000 US dollars
- **Kyprolis - Non-US**: 112,000,000 US dollars
- **Nplate - UNITED STATES**: 283,000,000 US dollars
- **Nplate - Non-US**: 129,000,000 US dollars
- **Otezla - UNITED STATES**: 352,000,000 US dollars
- **Otezla - Non-US**: 79,000,000 US dollars
- **Other products - UNITED STATES**: 1,131,000,000 US dollars
- **Other products - Non-US**: 397,000,000 US dollars
- **Prolia - UNITED STATES**: 461,000,000 US dollars
- **Prolia - Non-US**: 266,000,000 US dollars
- **Repatha - UNITED STATES**: 465,000,000 US dollars
- **Repatha - Non-US**: 411,000,000 US dollars
- **TEPEZZA - UNITED STATES**: 424,000,000 US dollars
- **TEPEZZA - Non-US**: 66,000,000 US dollars
- **TEZSPIRE - UNITED STATES**: 343,000,000 US dollars
- **TEZSPIRE - Non-US**: 0 US dollars
- **UPLIZNA - UNITED STATES**: 246,000,000 US dollars
- **UPLIZNA - Non-US**: 16,000,000 US dollars
- **Vectibix - UNITED STATES**: 136,000,000 US dollars
- **Vectibix - Non-US**: 151,000,000 US dollars
- **XGEVA - UNITED STATES**: 228,000,000 US dollars
- **XGEVA - Non-US**: 183,000,000 US dollars
- **Product sales - UNITED STATES**: 5,773,000,000 US dollars
- **Product sales - Non-US**: 2,445,000,000 US dollars
- **Selling, general and administrative**: 1,602,000,000 US dollars
- **Research and development**: 1,719,000,000 US dollars
- **Other**: negative 113,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 16,836,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Components above reported revenue (calculated)**: negative 8,218,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

## Chart details: Revenue by Product and Service (18 categories)

- Page: https://plicit.ai/financials/amgn/fy2026-q1-income-statement/revenue-by-product-and-service-18-categories
- Chart image: https://plicit.ai/charts/amgn-fy2026-q1-revenue-by-product-and-service-18-categories-sankey.png

Income statement for 2026-01-01 through 2026-03-31. View: Product and service (18 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 8,618,000,000 US dollars
- **Cost of sales**: 2,744,000,000 US dollars
- **Gross profit (calculated)**: 5,874,000,000 US dollars
- **Operating expenses (calculated)**: 3,208,000,000 US dollars
- **Operating income**: 2,666,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 582,000,000 US dollars
- **Income before income taxes**: 2,084,000,000 US dollars
- **Provision for income taxes**: 265,000,000 US dollars
- **Net income**: 1,819,000,000 US dollars
- **Repatha**: 876,000,000 US dollars
- **Prolia**: 727,000,000 US dollars
- **EVENITY**: 562,000,000 US dollars
- **TEPEZZA**: 490,000,000 US dollars
- **Otezla**: 431,000,000 US dollars
- **BLINCYTO**: 415,000,000 US dollars
- **Nplate**: 412,000,000 US dollars
- **XGEVA**: 411,000,000 US dollars
- **TEZSPIRE**: 343,000,000 US dollars
- **Kyprolis**: 330,000,000 US dollars
- **ENBREL**: 320,000,000 US dollars
- **Aranesp**: 311,000,000 US dollars
- **Vectibix**: 287,000,000 US dollars
- **UPLIZNA**: 262,000,000 US dollars
- **IMDELLTRA/IMDYLLTRA**: 258,000,000 US dollars
- **KRYSTEXXA**: 255,000,000 US dollars
- **Other products**: 1,528,000,000 US dollars
- **Other revenues**: 400,000,000 US dollars
- **Selling, general and administrative**: 1,602,000,000 US dollars
- **Research and development**: 1,719,000,000 US dollars
- **Other**: negative 113,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (2 categories)

- Page: https://plicit.ai/financials/amgn/fy2026-q1-income-statement/revenue-by-product-and-service-2-categories
- Chart image: https://plicit.ai/charts/amgn-fy2026-q1-revenue-by-product-and-service-2-categories-sankey.png

Income statement for 2026-01-01 through 2026-03-31. View: Product and service (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 8,618,000,000 US dollars
- **Cost of sales**: 2,744,000,000 US dollars
- **Gross profit (calculated)**: 5,874,000,000 US dollars
- **Operating expenses (calculated)**: 3,208,000,000 US dollars
- **Operating income**: 2,666,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 582,000,000 US dollars
- **Income before income taxes**: 2,084,000,000 US dollars
- **Provision for income taxes**: 265,000,000 US dollars
- **Net income**: 1,819,000,000 US dollars
- **Product sales**: 8,218,000,000 US dollars
- **Other revenues**: 400,000,000 US dollars
- **Selling, general and administrative**: 1,602,000,000 US dollars
- **Research and development**: 1,719,000,000 US dollars
- **Other**: negative 113,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.